Abbott's BinaxNOW Rapid Antigen Self Test Receives FDA Emergency Use Authorization for Asymptomatic, Over-the-Counter, Non-Prescription, Multi-Test Use Medical Device Investing
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages BELLUS Health Inc. Investors with Large Losses to Secure Counsel Before Important Deadline in Securities Class Action - BLU Biotech Investing
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Plug Power, XL Fleet Corp., Bellus Health, and Neptune Wellness and Encourages Investors to Contact the Firm Biotech Investing
Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against  BELLUS Health, Inc.- BLU Biotech Investing
/R E P E A T -- Sirona Biochem Reports Excellent Results in New Clinical Study on TFC-1067/ Biotech Investing
Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Adolescents Pharmaceutical Investing